Applying Occupational Health and Health Communications Principles Outside the Classroom
January 11, 2021
Originally from Narragansett, Rhode Island, Victoria Gallogly was intrigued by Drexel University due to its urban setting. “I’m from a small New England beach town and was looking to expand my worldview and experience city living,” she said. “Dornsife and Philadelphia in general had a very welcoming energy when I toured the university, which ultimately persuaded me to commit to Drexel University.”
During her freshmen year, Gallogly became interested in studying public health due to its focus on population health. “While the work of physicians is vital and important [especially during the pandemic], their work is largely focused on one individual at a time,” she said. “I want my career to be focused on improving people’s health and well-being at a broader societal level.”
Will treat racism as a ‘public health crisis’
Drexel University received a $9 million donation from alumna Dana Dornsife and her husband David to establish a new center dedicated to studying racism and public health issues.
The proposed Center on Racism and Health “will focus on structural racism and racial inequities in urban contexts and how these intersect with pressing population health challenges,” the university news release said.
Some of those health challenges include “police brutality and climate change.”
“All over the world there are renewed calls to address racism as the public health crisis that it is,” Ana Diez Roux, dean of the Dornsife School, said in the statement.
PrEP prescription can make a positive difference in women who inject drugs
When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effective way to prevent HIV transmission, according to the Centers for Disease Control and Prevention. Now a new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV.
The results, from researchers at Drexel University s Dornsife School of Public Health, Dornsife School of Public Health, were recently published in the
Journal of Acquired Immune Deficiency Syndrome.
In the first demonstration project among women who inject drugs, known as Project Sexual Health Equity (Project SHE), the team prescribed up to 24 weeks of daily PrEP, to 95 adult cisgender women those whose gender identity matches their sex assigned at birth. The study was based at the largest syringe services program in t
December 16, 2020
A new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV.
When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effectiveway to prevent HIV transmission, according to the Centers for Disease Control and Prevention. Now a new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV. The results, from researchers at Drexel University’s Dornsife School of Public Health, Dornsife School of Public Health, were recently published in the
E-Mail
When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effective way to prevent HIV transmission, according to the Centers for Disease Control and Prevention. Now a new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV. The results, from researchers at Drexel University s Dornsife School of Public Health, Dornsife School of Public Health, were recently published in the
Journal of Acquired Immune Deficiency Syndrome. In the first demonstration project among women who inject drugs, known as Project Sexual Health Equity (Project SHE), the team prescribed up to 24 weeks of daily PrEP, to 95 adult cisgender women those whose gender identity matches their sex assigned at birth. The study was based at the largest syringe services program in the mid-Atlantic Prevention Point Philadelphia located in the K